Active Ingredient(s):Lasmiditan Succinate FDA Approved: * October 11, 2019 Pharm Company: *ELI LILLY AND CO Category:Migraine / Tension Headache
Lasmiditan, sold under the brand name Reyvow, is a medication used for the acute (active but short-term) treatment of migraine with or without aura (a sensory phenomenon or visual disturbance) in adults. It is not useful for prevention. It is taken by mouth.
Common side effects include sleepiness, dizziness, tiredness, and numbness.
Lasmiditan was approved in the United States in October 2019 ...
* May have multiple approval dates, manufacturers, or labelers.